🇺🇸 FDA
Pipeline program

A Study to Investigate the Effect of RO7504109 on Immune Cells in Healthy Participants

BP45669

Phase 1 other active

Quick answer

A Study to Investigate the Effect of RO7504109 on Immune Cells in Healthy Participants for Not Applicable (N/A) is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Not Applicable (N/A)
Phase
Phase 1
Modality
other
Status
active

Clinical trials